| 货号 | 中文品名 | CAS No. | 别名 |
| WT-DM-C21971 | CL 387,785 | 194423-06-8 | EKB-785 |
| WT-DM-C21973 | UNC1079 | 1418741-86-2 | |
| WT-DM-C21975 | 2-(Phosphonomethyl)-pentanedioic Acid | 173039-10-6 | 2-PMPA |
| WT-DM-C21977 | HSP-990 | 934343-74-5 | NVP-HSP990 |
| WT-DM-C21980 | HS-173 | 1276110-06-5 | |
| WT-DM-C21981 | Aurora Kinase Inhibitor III | 879127-16-9 | |
| WT-DM-C21982 | Tenatoprazole | 113712-98-4 | TU-199 |
| WT-DM-C21983 | Trandolapril | 87679-37-6 | RU-44570 |
| WT-DM-C21988 | WZ4003 | 1214265-58-3 | |
| WT-DM-C21991 | Bafetinib | 859212-16-1 | INNO-406 |
| WT-DM-C21993 | JW 74 | 863405-60-1 | |
| WT-DM-C21994 | BC-11-38 | 686770-80-9 | |
| WT-DM-C21999 | EPZ011989 | 1598383-40-4 | |
| WT-DM-C22001 | Pomalidomide | 19171-19-8 | CC-4047 |
| WT-DM-C22002 | Diflunisal | 22494-42-4 | 5-(2,4-Difluorophenyl)salicylic Acid |
| WT-DM-C22004 | ND-336 | 1807453-83-3 | |
| WT-DM-C22005 | 2-Guanidinoethylmercaptosuccinic Acid | 77482-44-1 | GEMSA |
| WT-DM-C22007 | Onalespib | 912999-49-6 | AT-13387 |
| WT-DM-C22008 | KD 5170 | 940943-37-3 | |
| WT-DM-C22009 | E6 Berbamine | | |
| WT-DM-C22010 | RPI-1 | 269730-03-2 | |
| WT-DM-C22011 | ARRY-520 | 885060-09-3 | Filanesib |
| WT-DM-C22012 | 1-(4-Fluorophenyl)-2-methyl-2-propylamine | 1200-27-7 | |
| WT-DM-C22013 | BB-Cl-Amidine | 1802637-39-3 | |
| WT-DM-C22014 | 2-D08 | 144707-18-6 | |
| WT-DM-C22015 | KC02 | 1646795-60-9 | |
| WT-DM-C22016 | TAE-1 | 1414469-59-2 | |
| WT-DM-C22019 | OXA-01 | 936889-68-8 | |
| WT-DM-C22020 | LDN-57444 | 668467-91-2 | Ubiquitin C-terminal Hydrolase L1 Inhibitor |
| WT-DM-C22021 | KC01 | 1646795-59-6 | |
| WT-DM-C22022 | TFMB-R-2-HG | 1445700-01-5 | |
| WT-DM-C22024 | Trelagliptin | 865759-25-7 | SYR-472 |
| WT-DM-C22025 | PCNA-I1 | 444930-42-1 | |
| WT-DM-C22027 | BQU57 | 1637739-82-2 | |
| WT-DM-C22030 | Madrasin | 374913-63-0 | |
| WT-DM-C22032 | LDN-211904 | 1198408-78-4 | |
| WT-DM-C22033 | Hydroxytacrine (maleate) | 118909-22-1 | HP 029 |
| WT-DM-C22034 | Apremilast | 608141-41-9 | APR |
| WT-DM-C22035 | Ryuvidine | 265312-55-8 | Cdk4 Inhibitor III |
| WT-DM-C22037 | MI-77301 | 1303607-60-4 | SAR405838 |
| WT-DM-C22039 | HTH-01-015 | 1613724-42-7 | |
| WT-DM-C22040 | I-BRD9 | 1714146-59-4 | |
| WT-DM-C22041 | Cerivastatin (sodium salt) | 143201-11-0 | BAY-w 6228 |
| WT-DM-C22042 | HJC0197 | 1383539-73-8 | |
| WT-DM-C22044 | AP-III-a4 | 1177827-73-4 | ENOblock |
| WT-DM-C22045 | G? 6976 | 136194-77-9 | PD 406976 |
| WT-DM-C22048 | Tin Mesoporphyrin IX (chloride) | 106344-20-1 | NSC 267099 |
| WT-DM-C22049 | WYE-125132 | 1144068-46-1 | WYE-132 |
| WT-DM-C22052 | DDR1-IN-1 (hydrate) | | |
| WT-DM-C22053 | Crenolanib | 670220-88-9 | CP 868,596 |
| WT-DM-C22054 | PCI 24781 | 783355-60-2 | CRA-024781 |
| WT-DM-C22056 | (R)-Omeprazole (sodium salt) | 161796-77-6 | (R)-OMEP |
| WT-DM-C22058 | ME0328 | 1445251-22-8 | |
| WT-DM-C22060 | KIRA6 | 1589527-65-0 | IRE1 Inhibitor IV |
| WT-DM-C22064 | BIIB021 | 848695-25-0 | CNF2024 |
| WT-DM-C22066 | PHGDH-inactive | 1914971-16-6 | 3-Phosphoglycerate Dehydrogenase-inactive |
| WT-DM-C22070 | ASP3026 | 1097917-15-1 | |
| WT-DM-C22071 | EI1 | 1418308-27-6 | |
| WT-DM-C22072 | SGI-7079 | 1239875-86-5 | |
| WT-DM-C22073 | N-(3-Aminopropyl)acetamide | 4078-13-1 | |
| WT-DM-C22076 | Golgicide A | 1005036-73-6 | GCA |
| WT-DM-C22078 | NI-57 | 1883548-89-7 | |
| WT-DM-C22080 | Mps1-IN-2 | 1228817-38-6 | |
| WT-DM-C22081 | Cystamine (hydrochloride) | 56-17-7 | |
| WT-DM-C22082 | 9-amino Camptothecin | 91421-43-1 | NSC 603071 |
| WT-DM-C22083 | IDO-IN-1 | 914638-30-5 | |
| WT-DM-C22085 | (Z)-PUGNAc | 132489-69-1 | |
| WT-DM-C22087 | CVT-10216 | 1005334-57-5 | GS-455534 |
| WT-DM-C22091 | FLT3 Inhibitor | 301305-73-7 | Fms-like Tyrosine Kinase Inhibitor |
| WT-DM-C22094 | CRT5 | 1034297-58-9 | CRT0066051 |
| WT-DM-C22097 | EPZ004777 (formate) | C28H41N7O4 ? CH2O2 | |
| WT-DM-C22098 | EHT 1864 | 754240-09-0 | |
| WT-DM-C22099 | (3S,5S)-Atorvastatin (sodium salt) | 1428118-38-0 | |
| WT-DM-C22101 | IC261 | 186611-52-9 | SU5607 |
| WT-DM-C22105 | HG-9-91-01 | 1456858-58-4 | |
| WT-DM-C22107 | TAPI-1 | 171235-71-5 | TAPI |
| WT-DM-C22108 | VR23 | 1624602-30-7 | |
| WT-DM-C22110 | Buformin (hydrochloride) | 1190-53-0 | N-butyl Biguanide |
| WT-DM-C22111 | VER-155008 | 1134156-31-2 | |
| WT-DM-C22112 | SBC-115076 | 489415-96-5 | |
| WT-DM-C22115 | ESI-09 | 263707-16-0 | |
| WT-DM-C22118 | PRT4165 | 31083-55-3 | NSC 600157 |
| WT-DM-C22121 | BPIQ-I | 174709-30-9 | PD 159121 |
| WT-DM-C22123 | BPIQ-II (hydrochloride) | 171179-37-6 | PD 158294 |
| WT-DM-C22126 | GNF-5837 | 1033769-28-6 | |
| WT-DM-C22127 | MM-102 | 1417329-24-8 | |
| WT-DM-C22129 | UCM05 | 1094451-90-7 | G28UCM |
| WT-DM-C22130 | PPIase-Parvulin Inhibitor | 64005-90-9 | HIC 016C |
| WT-DM-C22131 | Mocetinostat | 726169-73-9 | MGCD0103 |
| WT-DM-C22134 | CH5424802 | 1256580-46-7 | Alectinib |
| WT-DM-C22135 | SP600125, negative control | 54642-23-8 | JNK Inhibitor II, negative control |
| WT-DM-C22140 | OSI-027 | 936890-98-1 | |
| WT-DM-C22142 | Oclacitinib | 1208319-26-9 | PF-03394197 |
| WT-DM-C22143 | Y11 | 1086639-59-9 | FAK Inhibitor 10 |
| WT-DM-C22145 | Dabigatran etexilate | 211915-06-9 | BIBR 1048 |
| WT-DM-C22147 | CH5183284 | 1265229-25-1 | Debio 1347 |
| WT-DM-C22148 | L-p-Bromotetramisole (oxalate) | 62284-79-1 | (-)-p-Bromotetramisole |
| WT-DM-C22150 | Carmofur | 61422-45-5 | HCFU |
| WT-DM-C22151 | Mitotane | 53-19-0 | o,p'-DDD |
| WT-DM-C22152 | Dabigatran | 211914-51-1 | BIBR 953 |
| WT-DM-C22154 | MCB-613 | 296792-62-6 | |
| WT-DM-C22155 | TIC10 | 1616632-77-9 | ONC201 |
| WT-DM-C22156 | Regorafenib | 755037-03-7 | BAY 73-4506 |
| WT-DM-C22161 | RWJ 67657 | 215303-72-3 | JNJ-3026582 |
| WT-DM-C22162 | SBI-0206965 | 1884220-36-3 | |
| WT-DM-C22163 | RU-SKI 43 (hydrochloride) | 1782573-67-4 | |
| WT-DM-C22165 | MS049 (hydrochloride) | 2095432-59-8 | |
| WT-DM-C22167 | ZSTK474 | 475110-96-4 | |
| WT-DM-C22168 | Pentoxifylline | 6493-05-6 | NSC 637086 |
| WT-DM-C22169 | Perhexiline (maleate) | 6724-53-4 | |
| WT-DM-C22170 | Oxyphenbutazone | 129-20-4 | G 27202 |
| WT-DM-C22171 | RAF265 | 927880-90-8 | CHIR265 |
| WT-DM-C22172 | Bortezomib | 179324-69-7 | LDP-341 |
| WT-DM-C22177 | HNMPA | 132541-52-7 | Hydroxy-2-naphthalenylmethyl Phosphonic Acid |
| WT-DM-C22180 | Tideglusib | 865854-05-3 | NP031112 |
| WT-DM-C22181 | TMPyP4 (tosylate) | 36951-72-1 | TMP-1363 |
| WT-DM-C22182 | NCT-501 (hydrochloride) | 2080306-22-3 | |
| WT-DM-C22185 | NNGH | 161314-17-6 | N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl Hydroxamic Acid |
| WT-DM-C22187 | CA-074 methyl ester | 147859-80-1 | |
| WT-DM-C22188 | R-59-022 | 93076-89-2 | Diacylglycerol Kinase Inhibitor I |
| WT-DM-C22191 | Rp-Cyclic AMPS (triethylammonium salt) | 151837-09-1 | Rp-cAMPS |
| WT-DM-C22192 | Imidapril (hydrochloride) | 89396-94-1 | TA-6366 |
| WT-DM-C22193 | Perindoprilat | 95153-31-4 | S-9780 |
| WT-DM-C22195 | D-Saccharic Acid 1,4-lactone (hydrate) | 61278-30-6 | D-Glucaro-1,4-lactone |
| WT-DM-C22196 | SirReal2 | 709002-46-0 | |
| WT-DM-C22197 | Ximelagatran | 192939-46-1 | Exanta |
| WT-DM-C22200 | VS-5584 | 1246560-33-7 | |
| WT-DM-C22203 | BVT 948 | 39674-97-0 | |
| WT-DM-C22204 | Fructose-1,6-bisphosphatase-1 Inhibitor | 883973-99-7 | F1,6BPase-1 Inhibitor |
| WT-DM-C22207 | Oxipurinol | 2465-59-0 | Alloxanthine |
| WT-DM-C22208 | IOX4 | 1154097-71-8 | |
| WT-DM-C22209 | JX-401 | 349087-34-9 | p38 MAPK Inhibitor VI |
| WT-DM-C22210 | NF-κB Activation Inhibitor III | 380623-76-7 | SM-7368 |
| WT-DM-C22211 | CL 82,198 | 307002-71-7 | |
| WT-DM-C22212 | Temocapril (hydrochloride) | 110221-44-8 | CS 622 |
| WT-DM-C22214 | XL888 | 1149705-71-4 | |
| WT-DM-C22216 | Vedaprofen | 71109-09-6 | Quadrisol |
| WT-DM-C22220 | Semagacestat | 425386-60-3 | LY450139 |
| WT-DM-C22223 | PRL-3 Inhibitor | 893449-38-2 | BR-1 |
| WT-DM-C22224 | MI-192 | 1415340-63-4 | |
| WT-DM-C22226 | Trequinsin (hydrochloride) | 78416-81-6 | |
| WT-DM-C22227 | R788 (sodium salt) | 1025687-58-4 | Fostamatinib |
| WT-DM-C22230 | Afuresertib (hydrochloride) | 1047645-82-8 | GSK2110183B |
| WT-DM-C22233 | IRAK-1/4 Inhibitor | 509093-47-4 | |
| WT-DM-C22234 | PI-3065 | 955977-50-1 | |
| WT-DM-C22235 | MF63 | 892549-43-8 | |
| WT-DM-C22236 | 6H05 (trifluoroacetate salt) | 2061344-88-3 | |
| WT-DM-C22237 | Ulixertinib (hydrochloride) | 1956366-10-1 | BVD-523 |
| WT-DM-C22238 | K02288 | 1431985-92-0 | |
| WT-DM-C22239 | Nexturastat A | 1403783-31-2 | |
| WT-DM-C22240 | K-Ras(G12C) Inhibitor 9 | 1469337-91-4 | Ki-Ras(G12C) Inhibitor 9 |
| WT-DM-C22245 | Pacritinib | 937272-79-2 | SB1518 |
| WT-DM-C22246 | ALK-IN-1 | 1197958-12-5 | |
| WT-DM-C22247 | LDN-214117 | 1627503-67-6 | |
| WT-DM-C22249 | Sephin1 | 13098-73-2 | NSC 65390 |
| WT-DM-C22250 | 4,5,6,7-Tetrabromobenzimidazole | 577779-57-8 | Casein Kinase II Inhibitor XII |
| WT-DM-C22254 | Avagacestat | 1146699-66-2 | BMS 708163 |
